Sydney Hanson
Nurse Practitioner · Butte, MTNPI 1336714997
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $7,703 of the $11,342 with a category attached, or 67.9%. 16 manufacturers reported payments, led by Abbott at 40.5% of the total. Reporting peaked in 2022 at $5,139 and has fallen 65.9% since, to $1,750 in 2025. Among nurse practitioner clinicians in MT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 94 payments — averaging $120.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$5K
- Livanova USA, Inc.$4K
- Medtronic$2K
- AbbVie$709
- Teva Pharmaceuticals USA, Inc.$216
- Nevro Corp.$173
- plus $558 from 10 others
What the payments were for
- Travel & lodging$7,70368%
- Food & beverage$3,59532%
- Education$450%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 18 | $4,593 |
| Livanova USA, Inc. | 11 | $3,554 |
| Medtronic | 14 | $1,540 |
| AbbVie(2 entities) | 19 | $709 |
| Teva Pharmaceuticals USA, Inc. | 9 | $216 |
| Nevro Corp. | 3 | $173 |
| Amgen | 2 | $119 |
| Boston Scientific | 3 | $98 |
| Merz Pharmaceuticals, LLC | 5 | $78 |
| Biogen | 1 | $72 |
| Globus Medical | 3 | $55 |
| Lundbeck LLC | 2 | $51 |
| Novartis | 1 | $41 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Nalu Medical, Inc. | 1 | $14 |
| Bayer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY$4,398
- VNS Therapy$3,203
- INTELLIS ADAPTIVESTIM$1,182
- UBRELVY$375
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$324
- QULIPTA$125
- AIMOVIG$101
How this compares
$11,342 in reported general payments places this provider in the 95th percentile of 357 nurse practitioner providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aimovig AutoinjectorErenumab-Aooe | 18 | $19,098 |
| Nurtec OdtRimegepant Sulfate | 14 | $17,677 |
| BriviactBrivaracetam | 11 | $15,181 |
| Emgality PenGalcanezumab-Gnlm | 13 | $9,144 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 78 | $1,940 |
| Gabapentin | 55 | $803 |
| Levetiracetam | 42 | $732 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 27 | $731 |
| Ropinirole Hcl | 32 | $690 |
| Lamotrigine | 27 | $603 |
| Sumatriptan Succinate | 22 | $573 |
| RizatriptanRizatriptan Benzoate | 48 | $486 |
| Donepezil Hcl | 65 | $305 |
| Topiramate | 22 | $280 |
| Memantine Hcl | 19 | $191 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Butte
- Jamie DeckerButte$3K
- Megan ReidButte$614
- Sarah BergMissoula$381K
- Arlon BennettFlorence$268K
- Jennifer TerrellBillings$7K
- Amanda Abrams-BuerkleyBillings$6K
- Bowen TrystiansonGreat Falls$6K
- Andrea LappBillings$4K
- Amber MolnarGreat Falls$4K
- Jessica BosoGreat Falls$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.